Investor Insights from CEOs & CFOs | seat11a

seat11a.com

seat11a.com brings you brief, high-impact pitches directly from public companies' CEOs, CFOs, and Investor Relations. Each episode focuses on Financial Results, Elevator Pitches, and Deep Dives, offering key insights into business models, strategies, and performance metrics. Perfect for investors seeking quick, reliable updates across various sectors. Stay ahead with concise, expert-led presentations that enhance your investment decisions in just minutes. Join thousands of investors who benefit from our podcast and take your investing to the next level!

  1. eDreams ODIGEO Financial Results 9M 2026 | EBITDA Growth, Prime Members & FY30 Target

    FEB 27

    eDreams ODIGEO Financial Results 9M 2026 | EBITDA Growth, Prime Members & FY30 Target

    eDreams ODIGEO Q3 FY26 Financial Results: Subscription Powerhouse Accelerating Toward €270M Cash EBITDA Target Presented by CFO David de la Elizaga David de la Elizaga, CFO of eDreams ODIGEO, presented the company’s Q3 FY26 results (nine months ending 31 December 2025), outlining a business undergoing a structural transition — but from a position of operational strength. Strong Underlying Profitability Adjusted EBITDA increased 74% year-on-year to €138.4 million, demonstrating the resilience of the core business. This metric excludes the temporary cash timing impact resulting from the shift from annual upfront Prime subscriptions to annual subscriptions paid in monthly instalments. Cash EBITDA reached €126.7 million (+2% YoY), despite: Investments in new products and geographies Temporary instability in Ryanair content Subscription payment timing effects Importantly, profitability per transaction improved: Cash Marginal Profit rose to €207.8 million (+3%) Cash Marginal Profit Margin expanded to 42% Cash EBITDA margin improved to 26% This signals increasing operating leverage as the Prime member base matures. Prime Membership: The Core Growth Engine Prime subscribers reached 7.7 million (+13% YoY), increasing to 7.8 million in January. Management reaffirmed the FY26 target of 7.9 million members. Prime-related revenue now represents 75% of Cash Revenue Margin, confirming the structural shift from transactional OTA to subscription-led travel platform. Higher customer lifetime value and improved loyalty metrics (+10% increase in NPS) further support the long-term model. Strategic Transition: Short-Term Cash Timing, Long-Term Value Creation The move to annual subscriptions paid monthly causes a temporary “one-time unwind” in cash metrics. However, the cash remains contractually secured and is collected over 12 months rather than upfront. This shift expands total addressable market, accelerates subscriber growth and diversifies revenue streams. By FY30, management targets: 13+ million Prime members €270+ million Cash EBITDA 1.5–2.0 million net adds annually (FY28–FY30) Cash EBITDA margin dip to ~15% in FY27 (investment year) Margin recovery to 23% by FY30 By FY30, 66% of volume will be diversified away from core European flight exposure. Valuation Disconnect At current share prices, the company trades at: 4.4x FY26 Cash EBITDA 4.0x Adjusted EBITDA This compares with: ~8.3x Global OTA average ~11.0x B2C subscription average Management believes the market significantly undervalues the structural improvement in business quality and long-term cash generation. Capital Allocation & Shareholder Returns eDreams reinforces confidence through aggressive capital return: €23M shares repurchased this quarter €100M buyback commitment through September 2027 12M shares already amortised (9.4% of share capital) ~24% of market capitalization pending repurchase at current prices This implies an exceptional yield profile rarely seen in growth-phase companies. Investment Thesis eDreams ODIGEO is transitioning into a high-margin, recurring revenue travel subscription leader. Despite temporary cash timing headwinds, operational profitability, subscription growth and strategic diversification remain intact. ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is for informational purposes only and does not constitute investment advice. Using this website, you agree to our terms and conditions outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

    14 min
  2. FEB 24

    JOST Werke SE Financial Results FY 2025 | Resilience, Cash Flow Strength, Margin Discipline

    JOST Werke SE delivered a resilient performance in FY 2025 despite a mixed macroeconomic backdrop across global commercial vehicle markets. While freight volumes and trailer registrations normalized in parts of Europe and North America, structural demand drivers such as fleet renewal, efficiency requirements, and regulatory standards remained intact. Revenue remained stable, supported by geographic diversification and a broad product portfolio spanning truck and trailer systems, axle solutions, and agricultural components. The company maintained a solid adjusted EBITDA margin, demonstrating strong pricing discipline and cost control. Operating and free cash flow generation remained robust, underlining JOST’s structural cash-generative profile. Margin stability in a moderating demand cycle reflects operational improvements implemented in recent years, including supply chain optimization, procurement efficiencies, and production flexibility. Agricultural and aftermarket activities provided additional resilience, while strong OEM relationships across Europe, North America, and Asia supported global positioning. The balance sheet remains solid, with controlled leverage, a healthy equity ratio, and continued deleveraging. Capital allocation stays disciplined, prioritizing organic growth, selective M&A, and sustainable shareholder returns. Strategically, JOST focuses on efficiency programs, digitalization, lightweight components, and sustainability-driven innovation. Electrification and evolving safety standards in commercial transport represent long-term growth opportunities. Overall, FY 2025 confirms JOST’s ability to navigate cyclical fluctuations while protecting margins and cash flow — reinforcing its positioning as a structurally improved, financially disciplined industrial supplier within global transport supply chains. ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

    9 min
  3. eDreams ODIGEO Deep Dive | Why Invest in eDO Now?

    FEB 4

    eDreams ODIGEO Deep Dive | Why Invest in eDO Now?

    eDreams ODIGEO's Deep Dive: Key Takeaways Presented by CFO David Elizaga eDreams ODIGEO is entering what management describes as a decisive inflection point in its corporate development. In this deep dive, David Elizaga, Chief Financial Officer, outlines why the company’s recent strategic shift represents not a defensive adjustment but a high-conviction move designed to unlock a significantly larger addressable market and a more predictable earnings profile over the long term. A Strategic Reset Focused on Long-Term Value Creation Management begins by directly addressing the sharp share price correction of roughly 60 percent following the November 2025 strategy update. The market reaction was driven primarily by the decision to introduce a monthly payment option for Prime subscriptions alongside the existing annual model. This change results in a one-time cash unwind in the short term, temporarily depressing reported Cash EBITDA and free cash flow in FY26 and FY27. Crucially, CFO David Elizaga stresses that this is a timing effect rather than a loss of value. The cash is still contractually secured but received over twelve months instead of upfront. In essence, eDreams is deliberately trading near-term cash acceleration for structurally higher market penetration, faster subscriber growth, and a more diversified revenue base. Why the Monthly Model Is a Growth Catalyst The introduction of monthly Prime subscriptions materially lowers the entry barrier for customers and significantly expands the total addressable market. Management now targets more than 13 million Prime members and over €270 million in Cash EBITDA by FY30. Beyond scale, the business mix improves meaningfully. The Prime platform becomes less dependent on European flights and increasingly diversified across geographies and travel products. By FY30, more than two thirds of volumes are expected to be generated outside the traditional European flight segment. Importantly, this transition is not theoretical. eDreams has already demonstrated its ability to scale Prime from roughly two million to over seven million members, giving management strong confidence in execution. Track Record of Delivering on Long-Term Plans A central pillar of the investment case is credibility. Since David Elizaga became CFO, eDreams has executed three long-term strategic plans, each time delivering on the guidance provided. The current strategy is framed as a continuation of this disciplined approach. Management highlights that the 2021 strategic plan involved significantly higher risk and was delivered successfully despite severe external shocks including the pandemic aftermath, geopolitical conflicts, inflation, and weak consumer sentiment. Against this backdrop, the CFO argues that the current valuation reaction does not reflect execution reality. Valuation Disconnect and Market Assumptions Management identifies a pronounced disconnect between internal expectations and sell-side valuation frameworks. Analysts are currently applying conservative assumptions across multiple dimensions.... ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

    12 min
  4. BRAIN Biotech AG Financial Results FY 2024 / 25 | Monetization, Margins & Enzyme growth initiatives

    JAN 17

    BRAIN Biotech AG Financial Results FY 2024 / 25 | Monetization, Margins & Enzyme growth initiatives

    Presented by CFO Michael Schneiders Brain Biotech AG has concluded the 2024/25 financial year with a clear strategic signal to capital markets: the company is increasingly translating its technology platform into tangible financial results through disciplined monetization, operational focus, and strict cost control. In the FY 2024/25 results presentation, Michael Schneiders, Chief Financial Officer, outlines how Brain Biotech is progressing from a technology-driven innovation platform toward a more cash-generative, scalable industrial biotechnology group. Strategic Focus: From Innovation to Monetization The 2024/25 financial year marked an important transition phase for Brain Biotech. Management placed a strong emphasis on monetizing selected assets and projects while maintaining technological leadership in enzyme innovation and industrial biotechnology. Rather than pursuing broad expansion, the company focused on converting prior R&D investments into measurable economic outcomes. This included milestone payments, licensing income, and structured partnerships, particularly within the enzyme and biocatalysis segments. These initiatives underline Brain Biotech’s ability to extract value from its technology portfolio without diluting strategic optionality. Cost Discipline and Margin Stabilization A defining feature of FY 2024/25 was the company’s strict cost discipline. Brain Biotech implemented targeted efficiency measures across the organization, prioritizing high-value activities while reducing structural overhead. This disciplined approach helped stabilize margins despite a challenging macroeconomic environment for biotechnology and life sciences companies. Management made clear that profitability and cash preservation are now core steering metrics, reinforcing investor confidence in Brain Biotech’s financial governance. Core Segment: Enzyme and Industrial Biotechnology Growth The enzyme business remains the operational backbone of Brain Biotech. The company continues to benefit from long-term structural demand for sustainable, energy-efficient, and biodegradable solutions across food, life sciences, and industrial applications. Brain Biotech’s integrated platform—combining biodiversity libraries, AI-supported enzyme discovery, and proprietary strain engineering—provides a competitive advantage in addressing customer-specific applications. Importantly, the company is increasingly shifting toward higher-margin, proprietary enzyme products rather than purely project-based revenues. AI as a Competitive Accelerator Artificial intelligence plays a growing role in Brain Biotech’s operating model. Management emphasized that AI is not a standalone strategy but a productivity and speed enhancer across enzyme discovery, optimization, and commercialization. By integrating AI-driven tools into its R&D and development processes, Brain Biotech shortens time-to-market, improves success rates, and strengthens customer value propositions—an increasingly relevant differentiator in industrial biotechnology. Financial Position and Capital Allocation From a balance sheet perspective, Brain Biotech remains focused on financial resilience. Cash management, selective capital allocation, and disciplined investment decisions underpin the group’s medium-term strategy. Management reiterated that future growth will be driven primarily by organic expansion in the enzyme segment, complemented by selective monetization of non-core or mature assets. M&A remains opportunistic rather than mandatory, ensuring financial flexibility in volatile markets... .. T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

    13 min
  5. Carl Zeiss Meditec AG Financial Results FY 2024/25 | Margin Outlook & Strategy Update

    12/17/2025

    Carl Zeiss Meditec AG Financial Results FY 2024/25 | Margin Outlook & Strategy Update

    Carl Zeiss Meditec AG FY 2024/25: Key Takeaways Carl Zeiss Meditec FY 2024/25 Financial Results Strategic Realignment Drives Resilient Growth and Sets the Stage for Margin Expansion In its FY 2024/25 financial results presentation, Carl Zeiss Meditec Group demonstrates that it remains firmly positioned in structurally attractive global healthcare technology markets, while simultaneously acknowledging the need for sharper execution and strategic focus to unlock its full earnings potential. The year was marked by solid revenue growth, robust order intake, and the first tangible effects of a broader strategic realignment aimed at restoring profitability momentum over the medium term. Solid Top-Line Growth and Strong Order Momentum Carl Zeiss Meditec delivered reported revenue of approximately €2.23 billion in FY 2024/25, reflecting solid growth compared with the prior year. On a foreign-exchange adjusted basis, revenue growth was clearly positive, supported by a combination of organic demand and the full-year consolidation of DORC in Ophthalmology. Order intake developed particularly strongly, increasing at a double-digit rate year-on-year on a constant-currency basis, resulting in a healthy order backlog that underpins revenue visibility into the new fiscal year. Growth was broad-based across regions. EMEA and the Americas showed especially strong momentum, while Asia-Pacific continued to contribute meaningfully despite a more challenging environment in China. Importantly for investors, order entry growth outpaced revenue growth, signalling ongoing demand strength across key product categories and geographies. Earnings: Stable EBITA Amid Headwinds, Adjusted Margin Improvement On the profitability side, EBITA increased slightly year-on-year, landing broadly in line with management guidance. Reported EBITA margin declined modestly compared with the prior year, reflecting a combination of adverse foreign exchange effects, US tariff-related headwinds, and a prior-year one-off gain related to the Topcon settlement. On an adjusted basis, however, EBITA margin improved, underlining the underlying progress in operating efficiency. A key positive driver was the reduction in underlying operating expenses excluding DORC effects, particularly through lower R&D spending and reduced integration costs. This demonstrates early discipline in capital allocation and cost management, even as the company continues to invest selectively in future growth areas. Segment Performance: Ophthalmology Strengths Offsets Microsurgery Transition Ophthalmology remained the group’s core earnings pillar. Consumables, premium intraocular lenses, and the full-year contribution from DORC drove revenue growth in this segment. Margin expansion in Ophthalmology was supported by operating leverage and improved cost discipline, reinforcing the segment’s role as the primary value driver within the portfolio. Microsurgery, while showing a recovery in revenue momentum toward year-end, continued to face margin pressure due to product mix effects, delayed ramp-up of new systems, and ongoing investments in commercialization and market development. Management clearly positioned this as a transitional phase, with expectations of improved profitability as new products scale and operational measures take effect. .... ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

    12 min
  6. Amadeus Fire AG Deep Dive | How Companies Build AI Skills at Scale

    12/14/2025

    Amadeus Fire AG Deep Dive | How Companies Build AI Skills at Scale

    Amadeus Fire AG Deep Dive: Q&A Building AI-Literate Organisations: A Strategic Framework In this deep dive, Amadeus Fire Group’s Chief Operating Officer, Monika Wiederhold, outlines a comprehensive framework for building AI-literate organisations, addressing one of the most pressing structural challenges in today’s corporate landscape. However, organizations may face barriers such as resource constraints, resistance to change, or skill gaps that could hinder implementation. Recognizing these challenges upfront enables leaders to develop targeted strategies for overcoming them. Wiederhold emphasizes that AI is no longer a specialised skill for data scientists but a shared responsibility across all levels, from supervisory boards to trainees. Recognizing this can foster a sense of collective purpose and motivate every employee to engage in AI learning quickly and continuously. The Three-Layer Learning Model Wiederhold introduces a structured, three-layer learning model that companies must adopt to remain competitive: 1. Horizontal Learning (AI fundamentals for everyone) The foundational layer focuses on universal AI knowledge, including responsible AI use, prompting, AI basics, legal obligations, and workplace tools such as Microsoft Copilot. These skills must be mandatory and company-wide to create a shared understanding of AI’s applications and risks. Horizontal learning provides the organisational baseline that enables fast adoption and prevents knowledge silos. 2. Vertical Learning (AI skills tailored to each function) Different functions require specialised AI training to enhance productivity and decision-making in their respective domains. Examples include: – Accounting: AI-supported financial workflows, automated reconciliation, and specialised certifications created within the Amadeus Fire Group. – Marketing: Creative AI tools, generative content systems, text-to-image/video technologies, and performance optimisation. – HR: Recruiting agents, interview support tools, talent analytics, and skills-matching agents. This vertical layer ensures that AI is embedded in day-to-day business processes. 3. Continuous Micro-Learning (staying up-to-date with rapid AI evolution) Given the pace of AI innovation, traditional annual or quarterly learning formats are insufficient. Wiederhold emphasises the need for high-frequency learning routines—daily or weekly micro-learning modules that update employees on new tools, techniques, regulations, and best practices. Monthly learning cycles are already too slow for AI’s development curve. Operationalising the AI Learning Architecture Once these three content layers are defined, organisations must address the critical question of how to operationalise them. Wiederhold highlights several structural enablers that determine whether AI learning can scale: A Dedicated Digital Learning Platform Companies need an integrated platform capable of: – distributing learning content at scale, – personalising training paths, – adapting to different skill levels, – surfacing relevant micro-learning content, – enabling horizontal, vertical, and continuous learning simultaneously. This platform becomes the organisational backbone for developing AI capabilities. ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

    12 min
  7. Matador AG Elevator Pitch | Strategy, Returns & Portfolio Insights

    12/13/2025

    Matador AG Elevator Pitch | Strategy, Returns & Portfolio Insights

    Matador AG Elevator Pitch: Key Takeaways Overview of Matador Secondary Private Equity AG Matador Secondary Private Equity AG is a Swiss-listed investment company focused exclusively on the secondary private equity market, offering shareholders access to an asset class that has reliably delivered stable, double-digit returns for more than two decades. Founded in 2005 in Sarnen, Switzerland, the company invests in mature private equity fund stakes acquired at discounts to NAV, typically in the fund’s years 4–6. This approach reduces blind-pool risk, accelerates cash distributions, and provides consistent visibility on portfolio quality. Investment Strategy and Market Positioning Matador’s strategy is built on acquiring fund positions from high-quality private equity managers, often from sellers such as pension funds, family offices, or institutional investors who need liquidity or must rebalance portfolios. Because more than 50% of committed capital in these funds is typically already invested, Matador benefits from immediate exposure to existing portfolios, early distributions, and lower risk than primary private equity commitments. Portfolio Diversification Across Regions and Strategies The company’s portfolio is broadly diversified across regions, vintages, sectors, and investment styles, with exposure to more than 1,000 underlying companies. The core allocation focuses on U.S. mid- and small-cap buyouts, where operational improvements, buy-and-build strategies, and more resilient M&A activity drive steady value creation. The portfolio is complemented by selective exposure to large buyout, growth equity, and technology-oriented funds to ensure balanced long-term performance. Compounding Effect Through Continuous Reinvestment A key differentiator of Matador’s model is the continuous reinvestment of cash flows from underlying fund distributions, enabling ongoing portfolio expansion without additional capital outflows. Over time, this creates a powerful compounding effect. The company structure also eliminates redemption pressure or forced exits, allowing the investment horizon to remain fully long-term. Long-Term Track Record and Shareholder Alignment Matador’s track record reflects this disciplined approach: since inception in 2005, the company has generated more than 12% annual performance in CHF, supported by the stability and structural advantages of secondary private equity. Management, as the largest shareholder, is deeply aligned with investors, fostering trust and shared commitment. Costs remain lean and performance-driven, reinforcing the company’s scalability and reliability. Investor Takeaway For shareholders, Matador offers transparent and liquid access to an institutional-grade private equity strategy with a proven return profile, broad diversification, limited cyclicality, and attractive long-term compounding. This approach aims to make private equity more understandable and accessible, fostering confidence in the investment process. ▶️ Other videos: Elevator Pitch: https://seat11a.com/investor-relations-elevator-pitch/ Company Presentation: https://seat11a.com/investor-relations-company-presentation/ Deep Dive Presentation: https://seat11a.com/investor-relations-deep-dive/ Financial Results Presentation: https://seat11a.com/investor-relations-financial-results/ ESG Presentation: https://seat11a.com/investor-relations-esg/ T&C This publication is intended solely for informational purposes and does not constitute investment advice. By using this website, you agree to our terms and conditions as outlined on www.seat11a.com/legal and www.seat11a.com/imprint.

    10 min

About

seat11a.com brings you brief, high-impact pitches directly from public companies' CEOs, CFOs, and Investor Relations. Each episode focuses on Financial Results, Elevator Pitches, and Deep Dives, offering key insights into business models, strategies, and performance metrics. Perfect for investors seeking quick, reliable updates across various sectors. Stay ahead with concise, expert-led presentations that enhance your investment decisions in just minutes. Join thousands of investors who benefit from our podcast and take your investing to the next level!